SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-004755
Filing Date
2014-10-31
Accepted
2014-10-30 19:49:45
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctic-10q_20140930.htm 10-Q 1636953
2 EX-10.1 ctic-ex101_20140930817.htm EX-10.1 108893
3 EX-10.2 ctic-ex102_20140930621.htm EX-10.2 783986
4 EX-15 ctic-ex15_201409307.htm EX-15 3355
5 EX-31.1 ctic-ex311_201409306.htm EX-31.1 11132
6 EX-31.2 ctic-ex312_201409309.htm EX-31.2 12038
7 EX-32 ctic-ex32_201409308.htm EX-32 12413
  Complete submission text file 0001564590-14-004755.txt   5765734

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ctic-20140930.xml EX-101.INS 513850
9 XBRL TAXONOMY EXTENSION SCHEMA ctic-20140930.xsd EX-101.SCH 32588
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20140930_cal.xml EX-101.CAL 43780
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20140930_def.xml EX-101.DEF 87823
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20140930_lab.xml EX-101.LAB 256543
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20140930_pre.xml EX-101.PRE 195203
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 141184529
SIC: 2834 Pharmaceutical Preparations